Altre lingue Devyser Diagnostics AB

Azioni

DVYSR

SE0016588867

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:29:51 26/04/2024			Variaz. 5gg	Var. 1 gen.
105 ^SEK	+1,94%		+0,96%	+33,59%

25/04	Devyser riceve l'approvazione IVDR per il software di monitoraggio post-trapianto	CI
11/03	Devyser Diagnostics AB ottiene una svolta negli Stati Uniti con il test NGS per la fibrosi cistica	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Devyser Receives IVDR Approval for Post-Transplant Monitoring Software	25/04
Devyser partners with Hamilton to automate laboratory NGS workflows	23/04
Devyser receives MDSAP certification for Brazil	16/04
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test	11/03
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patient	29/02
Devyser Diagnostics AB Announces Study Publication Demonstrating dd-cfDNA Detection in Dual Donor Kidney Transplant Patient	29/02
Devyser Diagnostics Q4 - Better positioned than ever	21/02
Devyser Diagnostics AB publishes year-end report for January to December 2023	20/02
Devyser Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Devyser Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/02
Invitation to audiocast for Devyser’s Q4 report 2023	14/02
Devyser Diagnostics AB Announces Michael Uhlin, CSO Joins Management Team as of February 1, 2024	29/01
Devyser's US Lab Inks SEK25 Million Deal with UK Diagnostics Company Cyted	17/01
Devyser Genomic Laboratories Signs First Commercial Agreement with Cyted	17/01
Sweden’s Devyser Wins SEK1.5 Million Tender in Italy for Cystic Fibrosis Test Kits	15/01
Devyser Diagnostics AB Wins Tender for Cystic Fibrosis in Italy	15/01
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US	08/01
Devyser signs in vitro diagnostic agreement with Illumina to broaden access to its tests	08/01
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests	08/01
Sweden’s Devyser Wins $6 Million Tender for Cystic Fibrosis Diagnostic Tool in Italy	11/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Devyser Diagnostics AB

Azioni

DVYSR

SE0016588867

Altre lingue

Filtri